Investor Presentaiton

RETHINKING GLAUCOMA CARE Rethinking Treatment Attacking Two Leading Causes of Blindness $5B global glaucoma market $3B global retinal equipment market Initial Glaucoma Traction Proven: ✓ Recurring revenue procedure probes ✓ Significant and growing worldwide installed base ✓ Expansive clinical studies and KOL support ✓ 150K+ procedures proven safe and effective ✓ Established attractive reimbursement Source: Market Scope estimates Growth through converting proven traction into significant market penetration IRIDEX

View entire presentation